Clinical Research Directory
Browse clinical research sites, groups, and studies.
MicroRNA as Markers in Testicular Cancer
Sponsor: Haukeland University Hospital
Summary
The main objective of this study is establish the performance of miR371 in management of testicular cancer
Official title: MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours
Key Details
Gender
MALE
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2016-12-31
Completion Date
2026-12-31
Last Updated
2022-08-08
Healthy Volunteers
No
Conditions
Interventions
Biomarker analysis
Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months
Locations (6)
Haukeland University Hospital
Bergen, Norway
Haugesund Hospital
Haugesund, Norway
Oslo University Hospital
Oslo, Norway
University Hospital of North Norway
Tromsø, Norway
Sahlgrenska University Hospital
Gothenburg, Sweden
Karolinska University Hospital
Stockholm, Sweden